{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:24:13Z","timestamp":1789640653742,"version":"4.0.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejso.2022.03.005","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T13:35:06Z","timestamp":1647524106000},"page":"1455-1463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Meta-analysis on prognostic value of KRAS mutation in resected mass-forming cholangiocarcinoma"],"prefix":"10.1016","volume":"48","author":[{"given":"Fabio","family":"Procopio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5058-9827","authenticated-orcid":false,"given":"Bruno","family":"Branciforte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Nappo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Di Tommaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0561-7902","authenticated-orcid":false,"given":"Ana","family":"Lleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5798-5021","authenticated-orcid":false,"given":"Guido","family":"Torzilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejso.2022.03.005_bib1","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.ejso.2022.03.005_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1148\/radiographics.22.1.g02ja15173","article-title":"Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings","volume":"22","author":"Han","year":"2002","journal-title":"Radiographics"},{"issue":"6","key":"10.1016\/j.ejso.2022.03.005_bib3","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1007\/s00330-018-5898-9","article-title":"A\u00a0proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance","volume":"29","author":"Rhee","year":"2019","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.ejso.2022.03.005_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000449493","article-title":"Current status on cholangiocarcinoma and gallbladder cancer","volume":"6","author":"Ebata","year":"2016","journal-title":"Liver Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2022.03.005_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.ejso.2022.03.005_bib6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","article-title":"Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis","volume":"149","author":"Mavros","year":"2014","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.ejso.2022.03.005_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1245\/s10434-015-4642-9","article-title":"Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection","volume":"23","author":"Spolverato","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2022.03.005_bib8","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.2012.41.5984","article-title":"Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy","volume":"31","author":"Wang","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2022.03.005_bib9","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1245\/s10434-019-07353-4","article-title":"Recurrence patterns and timing courses following curative-intent resection for intrahepatic cholangiocarcinoma","volume":"26","author":"Hu","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2022.03.005_bib10","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1245\/s10434-019-07483-9","article-title":"Therapeutic index associated with lymphadenectomy among patients with intrahepatic cholangiocarcinoma: which patients benefit the most from nodal evaluation?","volume":"26","author":"Sahara","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.03.005_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jso.20792","article-title":"Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases","volume":"96","author":"Shimada","year":"2007","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2022.03.005_bib12","article-title":"Prognostic value of resection margin length after surgical resection for intrahepatic cholangiocarcinoma","author":"Zhu","year":"2020","journal-title":"Am J Surg"},{"issue":"11","key":"10.1016\/j.ejso.2022.03.005_bib13","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s11605-019-04184-2","article-title":"Survival after resection of multiple tumor foci of intrahepatic cholangiocarcinoma","volume":"23","author":"Buettner","year":"2019","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"12","key":"10.1016\/j.ejso.2022.03.005_bib14","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1245\/s10434-018-6669-1","article-title":"Patterns of distribution of hepatic nodules (single, satellites or multifocal) in intrahepatic cholangiocarcinoma: prognostic impact after surgery","volume":"25","author":"Conci","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.03.005_bib15","doi-asserted-by":"crossref","first-page":"619e26","DOI":"10.1097\/SLA.0b013e3182a5025a","article-title":"RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases","volume":"258","author":"Vauthey","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.03.005_bib16","doi-asserted-by":"crossref","first-page":"3965e71","DOI":"10.1002\/cncr.28954","article-title":"KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases","volume":"120","author":"Kemeny","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2022.03.005_bib17","doi-asserted-by":"crossref","first-page":"2635e43","DOI":"10.1245\/s10434-016-5187-2","article-title":"RAS mutation predicts positive resection margins and narrower resection margins in patients undergoing resection of colorectal liver metastases","volume":"23","author":"Brudvik","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2022.03.005_bib18","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1245\/s10434-015-5046-6","article-title":"Cholangiocarcinoma heterogeneity revealed by multigene mutational profiling: clinical and prognostic relevance in surgically resected patients","volume":"23","author":"Ruzzenente","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2022.03.005_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115383","article-title":"Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications","volume":"9","author":"Churi","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ejso.2022.03.005_bib20","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/PAS.0000000000000670","article-title":"Distinct clinicopathologic and genetic features of 2 histologic subtypes of intrahepatic cholangiocarcinoma","volume":"40","author":"Hayashi","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2022.03.005_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4137\/JCM.S40549","article-title":"KRAS mutation as a potential prognostic biomarker of biliary tract cancers","volume":"7","author":"Yokoyama","year":"2016","journal-title":"Jpn Clin Med"},{"issue":"5","key":"10.1016\/j.ejso.2022.03.005_bib22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2018.01.009","article-title":"Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations","volume":"68","author":"Wardell","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"14","key":"10.1016\/j.ejso.2022.03.005_bib23","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ejso.2022.03.005_bib24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","article-title":"Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis","volume":"149","author":"Mavros","year":"2014","journal-title":"JAMA Surg"},{"issue":"8","key":"10.1016\/j.ejso.2022.03.005_bib25","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.ejso.2022.03.005_bib26","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.03.005_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bpg.2015.03.001","article-title":"The role of adjuvant chemotherapy and radiotherapy for cholangiocarcinoma","volume":"29","author":"Howell","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"Suppl 15s","key":"10.1016\/j.ejso.2022.03.005_bib28","article-title":"A\u00a0multicenter, randomized phase II trial of gemcitabine and oxaliplatin (GEMOX) alone or in combination with biweekly cetuximab in the first-line treatment of advanced biliary cancer: interim analysis of the BINGO trial","volume":"27","author":"Malka","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"1\u20132","key":"10.1016\/j.ejso.2022.03.005_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000111117","article-title":"Cetuximab plus gemcitabine-oxaliplatin (GEMOX) in patients with refractory advanced intrahepatic cholangiocarcinomas","volume":"72","author":"Paule","year":"2007","journal-title":"Oncology"},{"issue":"11","key":"10.1016\/j.ejso.2022.03.005_bib30","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1093\/annonc\/mdt337","article-title":"Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology","volume":"24","author":"Borbath","year":"2013","journal-title":"Ann Oncol"},{"issue":"15","key":"10.1016\/j.ejso.2022.03.005_bib31","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"27","key":"10.1016\/j.ejso.2022.03.005_bib32","first-page":"1","article-title":"International stroke trial collaborative group; European carotid surgery trial collaborative group. Evaluating non-randomised intervention studies","volume":"7","author":"Deeks","year":"2003","journal-title":"Health Technol Assess"},{"issue":"7109","key":"10.1016\/j.ejso.2022.03.005_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"7414","key":"10.1016\/j.ejso.2022.03.005_bib34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejso.2022.03.005_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"10.1016\/j.ejso.2022.03.005_bib36","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.47.5.721","article-title":"Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver","volume":"47","author":"Tannapfel","year":"2000","journal-title":"Gut"},{"issue":"Suppl 3","key":"10.1016\/j.ejso.2022.03.005_bib37","doi-asserted-by":"crossref","first-page":"S675","DOI":"10.1245\/s10434-012-2224-7","article-title":"K-ras mutation is strongly associated with perineural invasion and represents an independent prognostic factor of intrahepatic cholangiocarcinoma after hepatectomy","volume":"19","author":"Chen","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2022.03.005_bib38","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.humpath.2013.07.026","article-title":"The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome","volume":"44","author":"Robertson","year":"2013","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1016\/j.ejso.2022.03.005_bib39","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1245\/s10434-014-3828-x","article-title":"Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets","volume":"21","author":"Zhu","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.03.005_bib40","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1038\/ncomms6696","article-title":"Mutational landscape of intrahepatic cholangiocarcinoma","volume":"5","author":"Zou","year":"2014","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ejso.2022.03.005_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12967-018-1475-x","article-title":"Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by (18)F-FDG-PET is associated with the KRAS mutation status and prognosis","volume":"16","author":"Ikeno","year":"2018","journal-title":"J\u00a0Transl Med"},{"issue":"12","key":"10.1016\/j.ejso.2022.03.005_bib42","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.hpb.2019.04.002","article-title":"Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification?","volume":"21","author":"Bagante","year":"2019","journal-title":"HPB (Oxford)"},{"issue":"1","key":"10.1016\/j.ejso.2022.03.005_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jso.25303","article-title":"Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection","volume":"119","author":"Huang","year":"2019","journal-title":"J\u00a0Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2022.03.005_bib44","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1046\/j.1365-2168.2000.01532.x","article-title":"Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma","volume":"87","author":"Weimann","year":"2000","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.ejso.2022.03.005_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s002689900233","article-title":"Intrahepatic cholangiocarcinoma","volume":"21","author":"Chu","year":"1997","journal-title":"World J Surg"},{"issue":"11","key":"10.1016\/j.ejso.2022.03.005_bib46","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/bjs.1800831108","article-title":"A\u00a0western surgical experience of peripheral cholangiocarcinoma","volume":"83","author":"Berdah","year":"1996","journal-title":"Br J Surg"},{"issue":"13","key":"10.1016\/j.ejso.2022.03.005_bib47","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.celrep.2017.06.008","article-title":"Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles","volume":"19","author":"Farshidfar","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.ejso.2022.03.005_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejca.2017.12.028","article-title":"PICCA study: panitumumab in combination with cisplatin\/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study","volume":"92","author":"Vogel","year":"2018","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2022.03.005_bib49","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/jgh.12505","article-title":"Clinicopathological and prognostic significances of EGFR, KRAS and BRAFmutations in biliary tract carcinomas in Taiwan","volume":"29","author":"Chang","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.ejso.2022.03.005_bib50","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejso.2019.12.004","article-title":"Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study","volume":"46","author":"Procopio","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.03.005_bib51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12328-014-0460-z","article-title":"Surgical treatment for intrahepatic cholangiocarcinoma","volume":"7","author":"Uenishi","year":"2014","journal-title":"Clin J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ejso.2022.03.005_bib52","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1245\/s10434-008-0227-1","article-title":"Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients","volume":"16","author":"Yedibela","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2022.03.005_bib53","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1245\/s10434-009-0631-1","article-title":"The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival","volume":"16","author":"Choi","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.03.005_bib54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jso.20792","article-title":"Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases","volume":"96","author":"Shimada","year":"2007","journal-title":"J\u00a0Surg Oncol"},{"issue":"28","key":"10.1016\/j.ejso.2022.03.005_bib55","doi-asserted-by":"crossref","first-page":"e4133","DOI":"10.1097\/MD.0000000000004133","article-title":"The effect of wide resection margin in patients with intrahepatic cholangiocarcinoma: a single-center experience","volume":"95","author":"Ma","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.ejso.2022.03.005_bib56","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1067\/msy.2000.104673","article-title":"Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma","volume":"127","author":"Inoue","year":"2000","journal-title":"Surgery"},{"issue":"11","key":"10.1016\/j.ejso.2022.03.005_bib57","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s11605-019-04184-2","article-title":"Survival after resection of multiple tumor foci of intrahepatic cholangiocarcinoma","volume":"23","author":"Buettner","year":"2019","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"11","key":"10.1016\/j.ejso.2022.03.005_bib58","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1046\/j.0007-1323.2001.01879.x","article-title":"Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma","volume":"88","author":"Shimada","year":"2001","journal-title":"Br J Surg"},{"issue":"1 Suppl","key":"10.1016\/j.ejso.2022.03.005_bib59","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1067\/msy.2002.119498","article-title":"Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities","volume":"131","author":"Shirabe","year":"2002","journal-title":"Surgery"},{"issue":"47","key":"10.1016\/j.ejso.2022.03.005_bib60","doi-asserted-by":"crossref","first-page":"9084","DOI":"10.3748\/wjg.v19.i47.9084","article-title":"Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series","volume":"19","author":"Li","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.ejso.2022.03.005_bib61","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/bjs.10827","article-title":"Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma","volume":"105","author":"Zhang","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2022.03.005_bib62","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12885-015-1345-3","article-title":"Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages","volume":"15","author":"Li","year":"2015","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.ejso.2022.03.005_bib63","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1245\/s10434-016-5205-4","article-title":"KRAS and combined KRAS\/TP53 mutations in locally advanced rectal cancer are independently associated with decreased response to neoadjuvant therapy","volume":"23","author":"Chow","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"17","key":"10.1016\/j.ejso.2022.03.005_bib64","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/cncr.30085","article-title":"Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases","volume":"122","author":"Margonis","year":"2016","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ejso.2022.03.005_bib65","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/annonc\/mdf226","article-title":"Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype","volume":"13","author":"Bazan","year":"2002","journal-title":"Ann Oncol"},{"issue":"Suppl 4","key":"10.1016\/j.ejso.2022.03.005_bib66","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1245\/s10434-016-5382-1","article-title":"Vascularity of intrahepatic cholangiocarcinoma on computed tomography is predictive of lymph node metastasis","volume":"23","author":"Yamamoto","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2022.03.005_bib67","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00268-001-0291-1","article-title":"Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma","volume":"26","author":"Suzuki","year":"2002","journal-title":"World J Surg"},{"issue":"11","key":"10.1016\/j.ejso.2022.03.005_bib68","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00268-008-9726-2","article-title":"Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma","volume":"32","author":"Shirai","year":"2008","journal-title":"World J Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322001275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322001275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:44:19Z","timestamp":1760060659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322001275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0748798322001275"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.03.005","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis on prognostic value of KRAS mutation in resected mass-forming cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}